Ngm Biopharmaceuticals Inc

+0.97 (+4.07%)
Other Pre-Announcement

NGM Bio Reports Q3 2020 Financial Results

Published: 11/12/2020 21:22 GMT
NGM Biopharmaceuticals Inc (NGM) - Ngm Bio Provides Business Highlights and Reports Third Quarter 2020 Financial Results.
Qtrly Net Loss per Share, Basic and Diluted $0.43.
Qtrly Related Party Revenue From Collaboration With Merck Was $23.5 Million Versus $21.6 Million.
Q3 Earnings per Share View $-0.38, Revenue View $19.8 Million -- Refinitiv Ibes Data (analyst estimates).